GrantsFeed
Grants & Funding

Portugal – Pharmaceutical products – 2023/0491 - VEDOLIZUMAB [300 MG PÓ CONC SOL INJ FRS] vs Sweden – Personal care products – Extern Remiss Hygien och städmaterial 2025

Side-by-side comparison of two grants.

AttributePortugal – Pharmaceutical products – 2023/0491 - VEDOLIZUMAB [300 MG PÓ CONC SOL INJ FRS]Sweden – Personal care products – Extern Remiss Hygien och städmaterial 2025
TypeTenderTender
Funding amount$221K$102.3M
DeadlineCloses 2026-08-14
RegionPRTSWE
SectorHealthHealth
FunderUnidade Local de Saúde Santa Maria, E.P.E.Adda Inköpscentral AB
Who it's for